[go: up one dir, main page]

NO20033796L - Melkesyrebakterier som middel til å behandle og forebygge allergi - Google Patents

Melkesyrebakterier som middel til å behandle og forebygge allergi

Info

Publication number
NO20033796L
NO20033796L NO20033796A NO20033796A NO20033796L NO 20033796 L NO20033796 L NO 20033796L NO 20033796 A NO20033796 A NO 20033796A NO 20033796 A NO20033796 A NO 20033796A NO 20033796 L NO20033796 L NO 20033796L
Authority
NO
Norway
Prior art keywords
treating
lactic acid
acid bacteria
preventing allergies
allergies
Prior art date
Application number
NO20033796A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033796D0 (no
Inventor
Beda M Stadler
Monique Vogel
Jacques-Edouard Germond
Rodolphe Fritsche
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20033796D0 publication Critical patent/NO20033796D0/no
Publication of NO20033796L publication Critical patent/NO20033796L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20033796A 2001-03-02 2003-08-26 Melkesyrebakterier som middel til å behandle og forebygge allergi NO20033796L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105138A EP1239032A1 (fr) 2001-03-02 2001-03-02 Bactéries lactiques en tant qu'agents pour le traitement et la prévention des allergies
PCT/EP2002/002326 WO2002086102A1 (fr) 2001-03-02 2002-03-04 Bacteries lactiques utilisees comme agents de traitement et de prevention des allergies

Publications (2)

Publication Number Publication Date
NO20033796D0 NO20033796D0 (no) 2003-08-26
NO20033796L true NO20033796L (no) 2003-10-31

Family

ID=8176657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033796A NO20033796L (no) 2001-03-02 2003-08-26 Melkesyrebakterier som middel til å behandle og forebygge allergi

Country Status (17)

Country Link
US (1) US7235395B2 (fr)
EP (2) EP1239032A1 (fr)
JP (1) JP2004528034A (fr)
KR (2) KR20030082950A (fr)
CN (1) CN1505678A (fr)
AR (1) AR035761A1 (fr)
AU (1) AU2002256639B2 (fr)
BR (1) BR0207749A (fr)
CA (1) CA2438833A1 (fr)
IL (1) IL157468A0 (fr)
MX (1) MXPA03007881A (fr)
NO (1) NO20033796L (fr)
NZ (1) NZ527861A (fr)
PL (1) PL367208A1 (fr)
RU (1) RU2312892C2 (fr)
WO (1) WO2002086102A1 (fr)
ZA (1) ZA200307680B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US8252314B2 (en) 2004-09-24 2012-08-28 Hill's Pet Nutrition, Inc. Hypoallergenic composition
KR101260533B1 (ko) * 2005-03-03 2013-05-06 가부시키가이샤 메이지 면역기능 조정제
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
WO2006130188A1 (fr) 2005-05-31 2006-12-07 The Iams Company Bifidobacteries de probiotiques felins
JP2007300849A (ja) * 2006-05-11 2007-11-22 Oji Paper Co Ltd ペットフード
WO2008093303A2 (fr) 2007-02-01 2008-08-07 The Iams Company Procédé de réduction de l'inflammation et du stress chez un mammifère
CN102028224B (zh) * 2007-06-21 2012-12-26 东宇生物科技股份有限公司 抗过敏的乳酸菌
KR100913405B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물
CN102046777A (zh) 2008-04-25 2011-05-04 龟田制菓株式会社 具有抗过敏作用的新乳酸菌、含该乳酸菌的抗过敏剂、食品及医药品组成物以及上述抗过敏剂的制造方法
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
AU2008361375B2 (en) * 2008-09-04 2014-05-22 Om Pharma Immunomodulatory extracts from Lactobacillus bacteria and methods of manufacturing and use thereof
BRPI1012849A2 (pt) * 2009-05-11 2018-06-19 Nestec Sa lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102695427B (zh) * 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物
BR112013000649A2 (pt) 2010-07-09 2016-05-31 Sumitomo Chemical Co processo para a produção de óxido de olefina
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
JP7041272B2 (ja) 2018-01-12 2022-03-23 ジーアイ・イノベイション・インコーポレイテッド プロバイオティクスおよびＩｇＥへの結合親和性を有するポリペプチドを含む組成物およびその使用
WO2024081219A1 (fr) 2022-10-14 2024-04-18 Csp Technologies, Inc. Récipient et procédé de stockage et de stabilisation de produits sensibles à l'humidité

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) * 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
GB9006400D0 (en) * 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
EP0550428A1 (fr) 1990-08-30 1993-07-14 Genesit Oy Vecteurs sondes de promoteurs pouvant se repliquer en e.coli, b.subtilis, lactococci et lactobacillus, ainsi que leurs utilisations
GB9125695D0 (en) 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
AU2149495A (en) 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
GB9518323D0 (en) 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
RU2193413C2 (ru) * 1996-03-01 2002-11-27 Новартис Аг Пептидные иммуногены для вакцинации и лечения аллергии
JPH09234078A (ja) 1996-03-04 1997-09-09 Meiji Milk Prod Co Ltd 乳酸菌用分泌ベクター及び該ベクターを用いたタンパク質の製造方法
PT925364E (pt) 1996-09-06 2003-03-31 Bioteknologisk Inst Sistema de expressao regulavel de bacterias de acido lactico
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
MXPA03001673A (es) * 2000-09-25 2003-06-09 Nestle Sa Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
DK1356073T3 (da) * 2000-10-20 2010-04-06 Bioneer As Fermenteringsfremgangsmåde til fremstilling af heterologe genprodukter i mælkesyrebakterier
AU2002211201B2 (en) * 2000-11-02 2007-05-31 The National University Of Singapore aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display

Also Published As

Publication number Publication date
AR035761A1 (es) 2004-07-07
EP1239032A1 (fr) 2002-09-11
AU2002256639B2 (en) 2006-10-19
CN1505678A (zh) 2004-06-16
PL367208A1 (en) 2005-02-21
EP1370640A1 (fr) 2003-12-17
RU2003129265A (ru) 2005-04-10
BR0207749A (pt) 2004-06-01
IL157468A0 (en) 2004-03-28
KR20080111172A (ko) 2008-12-22
KR20030082950A (ko) 2003-10-23
ZA200307680B (en) 2005-01-13
JP2004528034A (ja) 2004-09-16
MXPA03007881A (es) 2003-12-04
RU2312892C2 (ru) 2007-12-20
WO2002086102A1 (fr) 2002-10-31
NO20033796D0 (no) 2003-08-26
CA2438833A1 (fr) 2002-10-31
US7235395B2 (en) 2007-06-26
NZ527861A (en) 2005-02-25
US20040265290A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
NO20033796L (no) Melkesyrebakterier som middel til å behandle og forebygge allergi
IL194950A0 (en) Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
DE60217363D1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen
WO2005044199A3 (fr) Combinaison d'un inhibiteur de pompe a protons et d'un agent favorisant le sommeil
DK1362027T3 (da) Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
AU2003202196A1 (en) Devices and methods for heart valve treatment
AU2002359738A8 (en) Method of sterilizing heart valves
NO20044195L (no) Biofosfoninsyrer for behandling og prevensjon av osteoprose
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
NO20034995L (no) Aromatiske sulfonhydroksymater og deres anvendelse som proteaseinhibitorer
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
DE60200578D1 (de) Ozonsterilisationsverfahren
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
DE60203207D1 (de) Zange zur orthodontischen Behandlung
ITTO20010848A0 (it) Disposizione e metodo di purificazione o trattamento elettrochimico.
SE0301854L (sv) Antiigensättningsbehandling
DE60220837D1 (de) Sterilisator und sterilisationsverfahren
NO20010589D0 (no) Fremgangsmåte og sjöbasert anlegg for hydrokarbonbehandling
FI20040531A7 (fi) Insuliiniresistenttien tilojen hoitaminen ja diagnosointi
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
ATE333439T1 (de) Pflanzenkläranlage
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
IS6992A (is) Meðhöndlun á ADHD

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application